US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan [Yahoo! Finance]
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: Yahoo! Finance
The financing will fund a new agreement with the Naval Medical Research Command and Walter Reed Army Institute of Research, the latter being the largest biomedical research facility overseen by the DoD. The aim of the collaboration is to develop an enhanced formulation of Travelan for military use against pathogens that cause diarrhoea, according to a 16 August press release. The new version will target bacterial pathogens Campylobacter, Shigella and Enterotoxigenic E coli strains (ETEC) that are not present in the current product formulation. Travelan is an over-the-counter bovine colostrum product. Bovine colostrum is cow's milk secreted during the first few days after calving and contains a range of immunoglobulins, growth factors, and cytokines that help with immune protection. Travelan is a highly purified tablet preparation that prevents bacteria colonisation in the digestive tract associated with travellers' diarrhoea. The US DoD has already been working with Australia
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma [Yahoo! Finance]Yahoo! Finance
- Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewGlobeNewswire
- Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®GlobeNewswire
- Immuron CEO, Steven Lydeamore to present at the Emerging Growth ConferenceGlobeNewswire
- Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect [Yahoo! Finance]Yahoo! Finance
IMRN
Sec Filings
- 9/26/24 - Form 6-K
- 9/9/24 - Form 6-K
- 9/5/24 - Form 6-K
- IMRN's page on the SEC website